AstraZeneca Pharma
AstraZeneca Pharma Share Price Chart
AstraZeneca Pharma last traded at ₹5,924.50 (2026-10-13). Over the past month the stock moved -13.5%, three months the stock moved -34.1%, year the stock moved -33.7%. Its closing range over 52 weeks is ₹5,730.40 – ₹9,535.45, with the latest close 37.9% below the high.
Closing prices up to 2026-10-13.
About AstraZeneca Pharma
AstraZeneca Pharma India Ltd is engaged in the business of manufacture, distribution and marketing of pharmaceutical products.[1]
Part of AstraZeneca UK plc The company is promoted by AstraZeneca plc, a multinational pharmaceutical and biotechnology company headquartered in England. It has a diverse portfolio in various disease areas and has been successful in developing and manufacturing the Oxford-AstraZeneca COVID-19 vaccine. AstraZeneca Pharmaceuticals AB holds 75% of the company's shareholding.[1] [2]
Fundamentals
Quarterly Results
In the latest quarter (Jun 2026), AstraZeneca Pharma reported sales of ₹683.00 crore (+29.8%) and net profit of ₹38.00 crore (-32.1%), compared with the same quarter last year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Jun 2026 | 683.00 | 49.00 | 7.00 | 38.00 | 15.17 |
| Mar 2026 | 579.00 | 61.00 | 11.00 | 45.00 | 17.95 |
| Dec 2025 | 612.00 | 45.00 | 7.00 | 33.00 | 13.04 |
| Sep 2025 | 559.00 | 75.00 | 13.00 | 54.00 | 21.69 |
| Jun 2025 | 526.00 | 81.00 | 15.00 | 56.00 | 22.33 |
| Mar 2025 | 480.00 | 86.00 | 18.00 | 58.00 | 23.30 |
| Dec 2024 | 440.00 | 77.00 | 17.00 | 31.00 | 12.34 |
| Sep 2024 | 408.00 | 53.00 | 13.00 | 38.00 | 15.37 |
| Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|
| Sales growth | +31.2% | +43.8% | +25.3% | +35.6% | +37.0% | +39.1% | +20.6% | +29.8% |
| Operating profit growth | +0.0% | +413.3% | +75.5% | +113.2% | +41.5% | -41.6% | -29.1% | -39.5% |
| Net profit growth | -26.9% | +93.8% | +48.7% | – | +42.1% | +6.5% | -22.4% | -32.1% |
| EPS growth | -26.6% | +95.3% | +47.6% | – | +41.1% | +5.7% | -23.0% | -32.1% |
| OPM % | 13.0% | 17.0% | 18.0% | 15.0% | 13.0% | 7.0% | 11.0% | 7.0% |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
Annual Financials
In the latest year (Mar 2026), AstraZeneca Pharma reported sales of ₹2,276.00 crore (+32.6%) and net profit of ₹188.00 crore (+62.1%), compared with the previous year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Mar 2026 | 2,276 | 262.00 | 12.00 | 188.00 | 75.01 |
| Mar 2025 | 1,716 | 254.00 | 15.00 | 116.00 | 46.30 |
| Mar 2024 | 1,296 | 184.00 | 14.00 | 162.00 | 64.60 |
| Mar 2023 | 1,003 | 165.00 | 16.00 | 99.00 | 39.72 |
| Mar 2022 | 806.00 | 86.00 | 11.00 | 62.00 | 24.64 |
| Mar 2021 | 814.00 | 135.00 | 17.00 | 93.00 | 37.32 |
| Mar 2020 | 832.00 | 121.00 | 15.00 | 72.00 | 28.88 |
| Mar 2019 | 728.00 | 71.00 | 10.00 | 54.00 | 21.78 |
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|
| Sales growth | +27.5% | +14.3% | -2.2% | -1.0% | +24.4% | +29.2% | +32.4% | +32.6% |
| Operating profit growth | +54.3% | +70.4% | +11.6% | -36.3% | +91.9% | +11.5% | +38.0% | +3.1% |
| Net profit growth | +107.7% | +33.3% | +29.2% | -33.3% | +59.7% | +63.6% | -28.4% | +62.1% |
| EPS growth | +110.2% | +32.6% | +29.2% | -34.0% | +61.2% | +62.6% | -28.3% | +62.0% |
| OPM % | 10.0% | 15.0% | 17.0% | 11.0% | 16.0% | 14.0% | 15.0% | 12.0% |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
Shareholding
AI Analysis
No AI analysis generated yet for AstraZeneca Pharma.
Get Free AI Stock Analysis FREE →Latest News
-
AstraZeneca Pharma India accepts resignation of Dr. Sandeep Arora - scanx.trade
-
AstraZeneca Pharma Approves ₹36 Dividend; Shares Fall 0.78%
-
Astrazeneca Pharma India standalone net profit declines 32.06% in the June 2026 quarter - business-standard.com
-
AstraZeneca Pharma India Q1 Profit Drops to Rs 37.93 Cr
-
AstraZeneca Pharma rises on getting CDSCO nod to market Enhertu for additional indication
-
AstraZeneca Pharma gets CDSCO nod to market Enhertu for additional indication
-
AstraZeneca Pharma gets CDSCO nod to market Enhertu for additional indication - Business Standard
-
AstraZeneca Pharma faces ₹148.66 Cr NPPA demand for Symbicort overcharging - scanx.trade
-
AstraZeneca Pharma India gets CDSCO nod for additional Fasenra indication - Business Standard
-
Q4 Results: AstraZeneca Pharma Shares Down 7% Profit Drops Despite Strong Revenue Growth
Frequently Asked Questions
What is AstraZeneca Pharma's current stock price?
AstraZeneca Pharma shares were last quoted at ₹5,924.50 (+1.5% on the day). Use the Refresh price button on this page for the latest available price. Prices are for information only.
What is the P/E ratio of AstraZeneca Pharma?
AstraZeneca Pharma has a price-to-earnings (P/E) ratio of 92.67 and a price-to-book (P/B) ratio of 17.26. The industry P/E is 52.82.
What is the 52-week high and low of AstraZeneca Pharma?
The 52-week high of AstraZeneca Pharma is ₹9,850.00 and the 52-week low is ₹6,267.25.
What is the market cap of AstraZeneca Pharma?
The market capitalisation of AstraZeneca Pharma is about ₹15,718.75 crore.
How did AstraZeneca Pharma perform in its latest quarterly results?
In the latest quarter (Jun 2026), AstraZeneca Pharma reported sales of ₹683.00 crore (+29.8%) and net profit of ₹38.00 crore (-32.1%), compared with the same quarter last year.
Is AstraZeneca Pharma a good stock to buy?
This page is for information and is not investment advice. As per the data shown here, AstraZeneca Pharma has a 3-year ROE of 23.00%, 3-year profit growth of 15.00%. Review the fundamentals, quarterly results and AI analysis on StockSpin, and consult a SEBI-registered adviser before investing.
What is the promoter holding in AstraZeneca Pharma?
Promoters hold about 75.00% of AstraZeneca Pharma.
Which sector does AstraZeneca Pharma belong to?
AstraZeneca Pharma belongs to the Pharmaceuticals & Drugs sector.